Seton Medical Center

Austin, Texas 78705

1 studies enrolling now · 20 studies all time

What they study most

Acute Ischemic Stroke, Acute Myocardial Infarction, Brain Infarction, Cardiac Resynchronization Therapy, Cardio-pulmonary Bypass, Cardiovascular Disease, Cerebral Ischemia, Coronary Artery Bypass Graft, Coronary Artery Disease, Coronary Artery Stenosis, Coronary Disease, Coronary Stenosis

Studies at this site

• Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature — Recruiting now
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism — Running, not enrolling
• CREST-2 Long-term Observational Extension Study — Running, not enrolling
• Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) — Completed
• Absorb IV Randomized Controlled Trial — Completed
• Precision Event Monitoring for Patients With Heart Failure Using HeartLogic — Completed
• SHIELD II Clinical Investigation — Stopped early
• Prevention of Non-Surgical Bleeding by Management of HeartMate II Patients Without Antiplatelet Therapy — Completed
• Mild and Rapidly Improving Stroke Study — Completed
• PDA Post NICU Discharge — Completed
• Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial — Completed
• Albumin in Acute Ischemic Stroke Trial — Stopped early
• Study of a New Clinical Device for Reducing Body Core Temperature — Stopped early
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early
• Evaluation of Automatic Threshold Algorithms — Completed
• Implementation of Practice Standards for ECG Monitoring — Completed
• Effect of Pexelizumab on All-Cause Mortality and Myocardial Infarction in Patients Undergoing Coronary Artery Bypass Graft Surgery With Cardio-Pulmonary Bypass — Completed
• Evaluating the Ability of Zoledronic Acid to Reduce the Rate of Subsequent Osteoporotic Fractures After a Hip Fracture — Completed
• Ancrod (Viprinex™) for the Treatment of Acute, Ischemic Stroke — Stopped early